Hospira re-launches oxaliplatin injection in U.S.
Hospira Inc said it has re-launched oxaliplatin injection in the U.S. The world’s leading provider of injectible drugs and infusion technologies has launched the injection, its generic version of Sanofi’s chemotherapy medication Eloxatin®. The sale of Eloxatin last year in the U.S. was approximately $1.5 billion.
Joshua Gordon, Vice President, Specialty Pharmaceuticals, said, “We are excited to once again be able to provide this critical oncology drug to our patients and customers.” “Hospira is committed to bringing safe, lower-cost generic versions of important medications to the market as soon as possible, and in this case we’re able to do so a year ahead of patent expiration for the originator product, which will contribute to much-needed cost savings for our customers," he added.
The oxaliplatin injection is a widely used oncology agent used to help treat colon and colorectal cancer. The company will initially offer the injection in 50 mg and 100 mg single-use vials. It is a solution form of the product.
This injection was initially launched in August 2009 following a favorable ruling patent litigation with Sanofi.The company settled litigation with Sanofi in 2010 under the agreement which called for the eventual suspension of the sales of Hospira at the end of June 2010, with the right to re-launch the product in advance of the patent expiry, the news reports said.
Hospira Inc is a global market leader for the generic injectable pharmaceuticals. It is uniquely positioned to Advance Wellness by improving patent and caregiver safety while reducing the cost of healthcare.
LG launches purpose-built smart TV for hospitals
LG Business Solutions USA has announced two new hospital TVs that are designed to improve patient management and engagement while adhering to critical safety standards for healthcare facilities.
One of the TVs is LG's biggest ever screen for a hospital - the 65-inch 4K Ultra HD model. It has LG’s NanoCell display technology, enabling it to display vivid pictures, and provides built-in support for hospital pillow speakers and embedded broadband LAN capability, so hospitals can deliver video on demand without requiring a separate set-top box in the patient room.
It also includes configuration software with an intuitive interface for setting up the TV to work in a hospital setting, plus a software-enabled access point feature that turns the TV into a Wi-Fi hotspot.
The second TV screen is the 15-inch Personal Healthcare Smart Touch TV with a multi-touch screen. It is designed to be installed on an adjustable arm for use in shared spaces or smaller patient rooms and will support LG's new, modular LG AM-AC21EA video camera, and HD video communication.
Both include support for video conferencing, and are UL Certified for use in healthcare facilities, a global safety standard. They also feature LG’s integrated Pro:Centric hospital management solutions, allowing hospitals and LG’s patient engagement development partners to personalise a patient's room, providing entertainment, hospital information, services, patient education, and more.
Additionally its communication platform makes it possible to conduct video calls between patients and clinicians or family.
“Our newest LG hospital TVs reflect ongoing feedback from the industry and include capabilities integrated to meet the unique needs of a critical market” said Tom Mottlau, Director of Healthcare Solutions, LG Electronics USA.
“Our healthcare patient engagement development partners requested an upgradable version of webOS for our Pro:Centric smart TV platform so they could more easily introduce new features for their hospital customers. For the latest versions of webOS, LG worked closely with our partners to make their request a reality and to deliver a hospital TV platform that can evolve over time.”